Plain-English translation of NCT04547673 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are developing and testing an artificial intelligence-powered diagnostic system that analyzes images from a special camera (nasoendoscope) to detect nasopharyngeal carcinoma—a type of throat cancer—at its earliest stages. The system uses two types of imaging technology to help doctors identify suspicious tissue more reliably. By catching cancer early, patients have much better chances of successful treatment with radiation and chemotherapy.
Nasopharyngeal carcinoma is particularly common in certain parts of the world, including southern China, northern Africa, and Alaska. Early detection leads to much better outcomes than finding the cancer at an advanced stage. This trial aims to create a computer-aided tool that can help doctors spot cancerous tissue more consistently and accurately during routine endoscopic exams.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo a nasoendoscopic examination—a procedure where doctors use a thin, flexible camera to visualize your nasopharynx (the upper part of your throat behind your nose). During this examination, the new AI diagnostic system will analyze images captured using two imaging technologies to help identify any abnormal tissue. A tissue biopsy may be taken for final confirmation, and your information will help researchers train and validate this new computer-assisted detection tool.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China